1. Home
  2. BXC vs EOLS Comparison

BXC vs EOLS Comparison

Compare BXC & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BXC
  • EOLS
  • Stock Information
  • Founded
  • BXC 2004
  • EOLS 2012
  • Country
  • BXC United States
  • EOLS United States
  • Employees
  • BXC N/A
  • EOLS N/A
  • Industry
  • BXC Wholesale Distributors
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BXC Consumer Discretionary
  • EOLS Health Care
  • Exchange
  • BXC Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • BXC 869.2M
  • EOLS 702.2M
  • IPO Year
  • BXC 2004
  • EOLS 2018
  • Fundamental
  • Price
  • BXC $110.28
  • EOLS $13.48
  • Analyst Decision
  • BXC Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • BXC 3
  • EOLS 6
  • Target Price
  • BXC $135.67
  • EOLS $22.60
  • AVG Volume (30 Days)
  • BXC 57.8K
  • EOLS 695.8K
  • Earning Date
  • BXC 02-18-2025
  • EOLS 03-06-2025
  • Dividend Yield
  • BXC N/A
  • EOLS N/A
  • EPS Growth
  • BXC N/A
  • EOLS N/A
  • EPS
  • BXC 3.41
  • EOLS N/A
  • Revenue
  • BXC $2,954,424,000.00
  • EOLS $248,326,000.00
  • Revenue This Year
  • BXC N/A
  • EOLS $33.43
  • Revenue Next Year
  • BXC $4.41
  • EOLS $32.44
  • P/E Ratio
  • BXC $31.32
  • EOLS N/A
  • Revenue Growth
  • BXC N/A
  • EOLS 34.42
  • 52 Week Low
  • BXC $87.67
  • EOLS $9.25
  • 52 Week High
  • BXC $134.79
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • BXC 54.48
  • EOLS 67.23
  • Support Level
  • BXC $105.68
  • EOLS $9.25
  • Resistance Level
  • BXC $109.36
  • EOLS $11.66
  • Average True Range (ATR)
  • BXC 3.97
  • EOLS 0.63
  • MACD
  • BXC 1.55
  • EOLS 0.27
  • Stochastic Oscillator
  • BXC 93.77
  • EOLS 80.73

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: